Stoke Therapeutics, Inc. (STOK)
30.08
-1.28
(-4.08%)
USD |
NASDAQ |
May 15, 16:00
30.35
+0.27
(+0.90%)
After-Hours: 04:49
Stoke Therapeutics Profit Margin (Quarterly) : -802.7% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 13.29% |
| Krystal Biotech, Inc. | 48.07% |
| Scholar Rock Holding Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Zymeworks, Inc. | -1.83K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.77% |
| Return on Assets | -42.16% |
| Return on Invested Capital | -48.21% |
| Gross Profit Margin (Quarterly) | 83.19% |
| Operating Margin (Quarterly) | -857.6% |
| Return on Net Operating Assets | -804.2% |